EPIS B — Episurf Medical AB Share Price
0.000.00%
Last trade - 00:00- SEK78.89m
- SEK52.89m
- SEK13.10m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.17 | ||
| Price to Tang. Book | 2.56 | ||
| Price to Free Cashflow | n/a | ||
| Price to Sales | 5.6 | ||
| EV to EBITDA | n/a | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -102.97% | ||
| Return on Equity | -109.12% | ||
| Operating Margin | -517.02% | ||
Financial Summary
| Year End 31st Dec | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | SEKm | 7 | 6.9 | 6.9 | 10.6 | 13.1 | 21 | 38 | 19.39% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Episurf Medical AB is a Sweden-based medical technology company. It is engaged in the development, manufacture and marketing of implants and surgical drilling templates used in the treatment of local cartilage damage in knee joints. The Company’s product portfolio includes the Episealer, and individually customized implant used as a cartilage replacement for early-stage patients; and Epiguide, a drill guide designed to attach to the knee’s surface, as well as related surgical tools. The personalization of implants and instruments is based on magnetic resonance imaging (MRI) and enables less invasive treatment. The process of ordering and creation of patient-specific implants and surgical instruments is covered by software suite, microiFidelity, comprising microiClinic, microiDesign and microiManufacture. The main shareholder of the Company is Serendipity Ixora Fund AB.
Directors
- Dennis Stripe NEC (60)
- Pal Ryfors CEO (35)
- Veronica Wallin CFO (35)
- Katarina Flodstrom COO (46)
- Fredrik Zetterberg DMK (46)
- Michael Nasstrom OTH (32)
- Leif Ryd DRC (68)
- Wilder Fulford IND (63)
- Christian Krueger IND (53)
- Laura Shunk IND (63)
- Last Annual
- December 31st, 2024
- Last Interim
- March 31st, 2025
- Incorporated
- October 6th, 2008
- Public Since
- November 5th, 2010
- No. of Shareholders
- 9,105
- No. of Employees
- 27
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- OMX Nordic Exchange Stockholm
- Shares in Issue
- 653,064,692
- Address
- Karlavagen 60, STOCKHOLM, 114 49
- Web
- https://episurf.com/
- Phone
- +46 86120020
- Auditors
- Ohrlings PricewaterhouseCoopers AB
Upcoming Events for EPIS B
Q2 2025 Episurf Medical AB Earnings Release
Q3 2025 Episurf Medical AB Earnings Release
Similar to EPIS B
Acarix AB
OMX Nordic Exchange Stockholm
AddLife AB
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
ADDvise AB (publ)
OMX Nordic Exchange Stockholm
Arcoma AB
OMX Nordic Exchange Stockholm
FAQ
What is the Episurf Medical AB share price?
As of Today at 20:29 UTC, shares in Episurf Medical AB are trading at SEK0.12. This share price information is delayed by 15 minutes.
How has the Episurf Medical AB share price performed this year?
Shares in Episurf Medical AB last closed at SEK0.12 and the price had moved by -57.45% over the past 365 days. In terms of relative price strength the Episurf Medical AB share price has underperformed the FTSE Global All Cap Index by -58.51% over the past year.
What are the analyst and broker recommendations for Episurf Medical AB?
There is no consensus recommendation for this security.
Find out moreWhat is the Episurf Medical AB dividend yield?
Episurf Medical AB does not currently pay a dividend.
Does Episurf Medical AB pay a dividend?
Episurf Medical AB does not currently pay a dividend.
When does Episurf Medical AB next pay dividends?
Episurf Medical AB does not currently pay a dividend.
How do I buy Episurf Medical AB shares?
To buy shares in Episurf Medical AB you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
What is the market cap of Episurf Medical AB?
As of the previous close price of SEK0.12, shares in Episurf Medical AB had a market capitalisation of SEK78.89m.
Where are Episurf Medical AB shares listed?
Here are the trading details for Episurf Medical AB:
- Country of listing: Sweden
- Exchange: STO
- Ticker Symbol: EPIS B
What kind of share is Episurf Medical AB?
Based on an overall assessment of its quality, value and momentum Episurf Medical AB is currently classified as a Sucker Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
Is there a Episurf Medical AB share price forecast for 2025?
The analyst consensus target price for shares in Episurf Medical AB is SEK0.30. That is 148.34% above the last closing price of SEK0.12.
Analysts covering Episurf Medical AB currently have a consensus Earnings Per Share (EPS) forecast of for the next financial year.
Find out moreWhat is the trend in the Episurf Medical AB share price?
An important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Episurf Medical AB. Over the past six months, its share price has underperformed the FTSE Global All Cap Index by -16.45%.
As of the last closing price of SEK0.12, shares in Episurf Medical AB were trading -18.2% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
What is the Episurf Medical AB PE Ratio?
The Episurf Medical AB PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at SEK0.12.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Who are the key directors of Episurf Medical AB?
Episurf Medical AB's management team is headed by:
- Dennis Stripe - NEC
- Pal Ryfors - CEO
- Veronica Wallin - CFO
- Katarina Flodstrom - COO
- Fredrik Zetterberg - DMK
- Michael Nasstrom - OTH
- Leif Ryd - DRC
- Wilder Fulford - IND
- Christian Krueger - IND
- Laura Shunk - IND